SE0300994L - Nya kompositioner och stammar - Google Patents

Nya kompositioner och stammar

Info

Publication number
SE0300994L
SE0300994L SE0300994A SE0300994A SE0300994L SE 0300994 L SE0300994 L SE 0300994L SE 0300994 A SE0300994 A SE 0300994A SE 0300994 A SE0300994 A SE 0300994A SE 0300994 L SE0300994 L SE 0300994L
Authority
SE
Sweden
Prior art keywords
plantarum
strains
tannase
dsm
gen
Prior art date
Application number
SE0300994A
Other languages
English (en)
Other versions
SE0300994D0 (sv
SE527555C2 (sv
Inventor
Goeran Molin
Siv Ahrne
Bengt Jeppsson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Priority to SE0300994A priority Critical patent/SE527555C2/sv
Publication of SE0300994D0 publication Critical patent/SE0300994D0/sv
Priority to EP09176668.3A priority patent/EP2163162B1/en
Priority to PT04725573T priority patent/PT1613740E/pt
Priority to US13/910,278 priority patent/USRE46718E1/en
Priority to ZA200507938A priority patent/ZA200507938B/en
Priority to PCT/SE2004/000509 priority patent/WO2004087893A1/en
Priority to AT04725573T priority patent/ATE546516T1/de
Priority to US10/551,991 priority patent/US7507572B2/en
Priority to US13/070,715 priority patent/USRE44400E1/en
Priority to ES09176668T priority patent/ES2751101T3/es
Priority to CN2011100607082A priority patent/CN102210717B/zh
Priority to ES04725573T priority patent/ES2382930T3/es
Priority to RU2005134223/13A priority patent/RU2356942C2/ru
Priority to PL04725573T priority patent/PL1613740T3/pl
Priority to BRPI0409206A priority patent/BRPI0409206C1/pt
Priority to CN2004800153092A priority patent/CN1798831B/zh
Priority to BR122018068574-3A priority patent/BR122018068574B1/pt
Priority to JP2006507999A priority patent/JP4731469B2/ja
Priority to SI200431870T priority patent/SI1613740T1/sl
Priority to EP04725573A priority patent/EP1613740B1/en
Priority to PL09176668T priority patent/PL2163162T3/pl
Priority to KR1020057018900A priority patent/KR101122916B1/ko
Priority to DK04725573.2T priority patent/DK1613740T3/da
Priority to CA2521220A priority patent/CA2521220C/en
Priority to AU2004225568A priority patent/AU2004225568B2/en
Publication of SE0300994L publication Critical patent/SE0300994L/sv
Publication of SE527555C2 publication Critical patent/SE527555C2/sv
Priority to HK06114164.5A priority patent/HK1094004A1/xx
Priority to HK12103485.2A priority patent/HK1162937A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A23L1/3014—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/0102—Tannase (3.1.1.20)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/857—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
SE0300994A 2003-04-04 2003-04-04 Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar SE527555C2 (sv)

Priority Applications (27)

Application Number Priority Date Filing Date Title
SE0300994A SE527555C2 (sv) 2003-04-04 2003-04-04 Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
AU2004225568A AU2004225568B2 (en) 2003-04-04 2004-04-02 Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
RU2005134223/13A RU2356942C2 (ru) 2003-04-04 2004-04-02 Композиция, обладающая противовоспалительными свойствами, штамм lactobacillus plantarum - продуцент танназы (варианты) и его применения
BRPI0409206A BRPI0409206C1 (pt) 2003-04-04 2004-04-02 composições compreendendo cepas de lactobacillus em combinação com tanino e uso das referidas cepas de lactobacillus
US13/910,278 USRE46718E1 (en) 2003-04-04 2004-04-02 Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
ZA200507938A ZA200507938B (en) 2003-04-04 2004-04-02 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
PCT/SE2004/000509 WO2004087893A1 (en) 2003-04-04 2004-04-02 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
AT04725573T ATE546516T1 (de) 2003-04-04 2004-04-02 Lactobacillus plantarum-stämme in kombination mit tannin umfassende zusammensetzungen sowie neue lactobacillus plantarum-stämme
US10/551,991 US7507572B2 (en) 2003-04-04 2004-04-02 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
US13/070,715 USRE44400E1 (en) 2003-04-04 2004-04-02 Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
ES09176668T ES2751101T3 (es) 2003-04-04 2004-04-02 Composiciones que comprenden cepas de Lactobacillus plantarum en combinación con tanino y nuevas cepas de Lactobacillus plantarum
CN2011100607082A CN102210717B (zh) 2003-04-04 2004-04-02 含有与丹宁组合的植物乳杆菌菌株的组合物和新植物乳杆菌菌株
ES04725573T ES2382930T3 (es) 2003-04-04 2004-04-02 Composiciones que comprenden cepas de lactobacillus plantarum en combinación con tanino y nuevas cepas de lactobacillus plantarum
EP09176668.3A EP2163162B1 (en) 2003-04-04 2004-04-02 Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
PL04725573T PL1613740T3 (pl) 2003-04-04 2004-04-02 Kompozycje zawierające szczepy Lactobacillus plantarum w połączeniu z taniną i nowe szczepy Lactobacillus plantarum
PT04725573T PT1613740E (pt) 2003-04-04 2004-04-02 Composições que compreendem estirpes de lactobacillus plantarum em combinação com tanino e novas estirpes de lactobacillus plantarum
CN2004800153092A CN1798831B (zh) 2003-04-04 2004-04-02 含有与丹宁组合的植物乳杆菌菌株的组合物和新植物乳杆菌菌株
BR122018068574-3A BR122018068574B1 (pt) 2003-04-04 2004-04-02 Uso de uma cepa produtora de lactobacillus plantarum de tanase para a preparação de um medicamento para o tratamento profilático ou curativo de lesão por isquemia/reperfusão
JP2006507999A JP4731469B2 (ja) 2003-04-04 2004-04-02 タンニンと組み合わせてＬａｃｔｏｂａｃｉｌｌｕｓｐｌａｎｔａｒｕｍ株を含有する組成物、並びに、新規Ｌａｃｔｏｂａｃｉｌｌｕｓｐｌａｎｔａｒｕｍ株
SI200431870T SI1613740T1 (sl) 2003-04-04 2004-04-02 Sestavki, ki vsebujejo lactobacillus plantarum seve v kombinaciji s taninom in novi lactobacillus platarum sevi
EP04725573A EP1613740B1 (en) 2003-04-04 2004-04-02 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
PL09176668T PL2163162T3 (pl) 2003-04-04 2004-04-02 Kompozycje zawierające szczepy Lactobacillus plantarum w połączeniu z taniną i nowe szczepy Lactobacillus plantarum
KR1020057018900A KR101122916B1 (ko) 2003-04-04 2004-04-02 탄닌과 배합된 락토바실러스 플랜타룸 균주를 포함하는 조성물 및 락토바실러스 플랜타룸 균주
DK04725573.2T DK1613740T3 (da) 2003-04-04 2004-04-02 Sammensætninger omfattende stammer af Lactobacillus plantarum i kombination med garvesyre samt nye stammer af Lactobacillus plantarum
CA2521220A CA2521220C (en) 2003-04-04 2004-04-02 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
HK06114164.5A HK1094004A1 (en) 2003-04-04 2006-12-27 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
HK12103485.2A HK1162937A1 (en) 2003-04-04 2012-04-10 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300994A SE527555C2 (sv) 2003-04-04 2003-04-04 Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar

Publications (3)

Publication Number Publication Date
SE0300994D0 SE0300994D0 (sv) 2003-04-04
SE0300994L true SE0300994L (sv) 2004-10-05
SE527555C2 SE527555C2 (sv) 2006-04-11

Family

ID=20290933

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300994A SE527555C2 (sv) 2003-04-04 2003-04-04 Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar

Country Status (19)

Country Link
US (3) USRE46718E1 (sv)
EP (2) EP2163162B1 (sv)
JP (1) JP4731469B2 (sv)
KR (1) KR101122916B1 (sv)
CN (2) CN1798831B (sv)
AT (1) ATE546516T1 (sv)
AU (1) AU2004225568B2 (sv)
BR (2) BRPI0409206C1 (sv)
CA (1) CA2521220C (sv)
DK (1) DK1613740T3 (sv)
ES (2) ES2751101T3 (sv)
HK (2) HK1094004A1 (sv)
PL (2) PL1613740T3 (sv)
PT (1) PT1613740E (sv)
RU (1) RU2356942C2 (sv)
SE (1) SE527555C2 (sv)
SI (1) SI1613740T1 (sv)
WO (1) WO2004087893A1 (sv)
ZA (1) ZA200507938B (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
WO2007009187A1 (en) * 2005-07-22 2007-01-25 Tarac Technologies Pty Ltd Polyphenol and probiotic containing nutritional supplement
PL2277524T3 (pl) 2005-09-28 2016-06-30 Nordic Rebalance As Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia
RU2440123C2 (ru) * 2005-10-06 2012-01-20 Проби Аб Применение lactobacillus для лечения вирусных инфекций
US20080269142A1 (en) * 2006-10-23 2008-10-30 Ian Blair Endogenous thiadiazabicyclo glutathione-adduct
WO2008075949A1 (en) * 2006-12-20 2008-06-26 Friesland Brands B.V. Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms
PL2136825T3 (pl) * 2007-03-01 2014-04-30 Probi Ab Zastosowanie bakterii lactobacillus plantarum do zwiększania różnorodności bakteryjnej
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
JP5504254B2 (ja) * 2008-04-30 2014-05-28 ネステク ソシエテ アノニム コーヒーのクロロゲン酸に由来する脱炭酸したフェノール酸を含む生成物、及びその使用
MX2010011059A (es) * 2008-04-30 2010-11-12 Nestec Sa Composiciones para preparar una bebida de cafe que comprende acido clorogenico hidrolizado.
EE05341B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
EP2210505A1 (en) * 2009-01-27 2010-07-28 Nestec S.A. Composition comprising caftaric acid and/or derivatives thereof
EP2210504A1 (en) * 2009-01-27 2010-07-28 Nestec S.A. Composition comprising chicoric acid and/or derivatives thereof
CA2774963A1 (en) * 2009-10-09 2011-04-14 Prothera, Inc. Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease
JP5932662B2 (ja) * 2009-12-22 2016-06-08 プロビ アクティエボラーグ 穀物ベースフラクション及びプロバイオティックを含む非発酵組成物、並びにそれらの使用
TWI401086B (zh) * 2010-07-20 2013-07-11 Univ China Medical 胚芽乳酸桿菌及其用途
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
CN113151045A (zh) * 2011-06-10 2021-07-23 株式会社爱茉莉太平洋 分离自茶树叶的新型植物乳杆菌
KR101295444B1 (ko) * 2011-12-22 2013-08-09 웅진식품주식회사 신규한 홍삼 발효용 미생물, 이를 이용한 홍삼 발효액 및 홍삼 발효 음료
TWI463986B (zh) 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
EP3214952B1 (en) * 2014-11-05 2020-04-22 Optibiotix Limited Method of producing a prebiotic composition and its use
US10226492B2 (en) 2014-11-25 2019-03-12 Dsm Ip Assets B.V. Probiotic and new biomarker
RU2600445C1 (ru) * 2015-09-21 2016-10-20 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московская государственная академия ветеринарной медицины и биотехнологии - МВА имени К.И. Скрябина" (ФГБОУ ВО МГАВМиБ - МВА имени К.И. Скрябина) Способ биоиндикации состояния двухстворчатых моллюсков в условиях техногенного загрязнения среды обитания
GB201600975D0 (en) 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof
IT201700057079A1 (it) * 2017-05-25 2018-11-25 Probiotical Spa Batterioterapia a base di composizioni batteriche per il trattamento di malattie neurodegenerative
WO2019242839A1 (en) * 2018-06-18 2019-12-26 Probi Ab Lactobacillus plantarum compositions and uses thereof
KR102682981B1 (ko) * 2018-11-05 2024-07-11 마블바이옴 인코포레이티드 엘라기탄닌을 포함하는 미생물 조성물 및 사용 방법
WO2020181096A1 (en) * 2019-03-05 2020-09-10 The Texas A&M University System Combinations of tannase and probiotic formulations and methods of use for improving tannin metabolism
GB201908154D0 (en) * 2019-06-07 2019-07-24 Probi Ab Lactobacillus compositions and uses thereof
CN111500655B (zh) * 2020-03-19 2021-03-05 北京北农科技有限公司 一种五倍子单宁制备新工艺
CN112386614B (zh) * 2020-11-25 2022-11-08 天津科技大学 植物乳杆菌ma2在制备预防或改善阿尔茨海默症药物或食品方面中的应用
KR102390694B1 (ko) * 2021-07-13 2022-04-29 한국식품연구원 락티플란티바실러스 파라플란타룸 WiKim0130을 포함하는 암의 예방, 개선 또는 치료용 조성물
CN114107161B (zh) * 2021-11-15 2023-06-20 泸州老窖股份有限公司 一种混合驯化菌株降解石榴皮生产鞣花酸的方法
CN113980858B (zh) * 2021-11-18 2023-05-02 上海植酵盛生物科技有限公司 一株产高活性单宁酶的植物乳杆菌yl399及其在制备党参发酵饲料中的应用
CN117384879B (zh) * 2023-01-13 2024-04-30 中国农业科学院茶叶研究所 一种适应茶汁体系的耐酸单宁酶制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453763A1 (fr) 1979-04-14 1980-11-07 Teves Gmbh Alfred Regulateur de force de freinage a deux circuits, comportant un piston d'arret actionnable hydrauliquement
JPS5785326A (en) 1980-11-14 1982-05-28 Asahi Glass Co Ltd Stabilization of flon
JPS6425726A (en) 1987-04-24 1989-01-27 Yuutoku Yakuhin Kogyo Kk Agent for eliminating active oxygen free radical
SE463796B (sv) * 1988-03-09 1991-01-28 Carl Erik Albertsson Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition
SE469875C (sv) 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JP3459837B2 (ja) * 1992-05-12 2003-10-27 太陽化学株式会社 生菌粉末
JP4127863B2 (ja) 1993-03-04 2008-07-30 太陽化学株式会社 腸内環境改善組成物
SE9501056D0 (sv) * 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
SE9501719D0 (sv) * 1995-05-09 1995-05-09 Probi Ab Pharmaceutical composition
SE510753C2 (sv) * 1997-08-05 1999-06-21 Probi Ab Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
CA2345110A1 (en) * 1998-10-01 2000-04-13 Probi Ab Reduction of oxidative stress factors
FR2789580A1 (fr) 1999-02-12 2000-08-18 Oreal Compositions cosmetiques antisolaires a base d'un melange synergique de filtres et utilisations
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
SE0004124D0 (sv) 2000-11-10 2000-11-10 Probi Ab New use
KR100549193B1 (ko) * 2002-10-23 2006-02-02 (주)바이오뉴트리젠 인삼 및 폴리페놀계 물질 또는 바이오플라보노이드계 물질을 포함하는 식물의 분말 또는 추출물을 포함하는 항비만용 식품

Also Published As

Publication number Publication date
ES2751101T3 (es) 2020-03-30
EP1613740B1 (en) 2012-02-22
KR101122916B1 (ko) 2012-06-13
CN102210717B (zh) 2013-02-06
USRE46718E1 (en) 2018-02-20
EP2163162B1 (en) 2019-08-07
CA2521220A1 (en) 2004-10-14
DK1613740T3 (da) 2012-05-21
WO2004087893A1 (en) 2004-10-14
PL1613740T3 (pl) 2012-07-31
USRE44400E1 (en) 2013-07-30
KR20060005356A (ko) 2006-01-17
SE0300994D0 (sv) 2003-04-04
PL2163162T3 (pl) 2020-02-28
SI1613740T1 (sl) 2012-09-28
BRPI0409206B8 (pt) 2019-01-22
AU2004225568A1 (en) 2004-10-14
ATE546516T1 (de) 2012-03-15
CN1798831B (zh) 2011-05-18
EP1613740A1 (en) 2006-01-11
JP4731469B2 (ja) 2011-07-27
US7507572B2 (en) 2009-03-24
HK1094004A1 (en) 2007-03-16
RU2005134223A (ru) 2006-03-10
BRPI0409206C1 (pt) 2021-05-25
RU2356942C2 (ru) 2009-05-27
BRPI0409206A (pt) 2006-03-28
ZA200507938B (en) 2007-03-28
AU2004225568B2 (en) 2008-02-14
CN1798831A (zh) 2006-07-05
EP2163162A1 (en) 2010-03-17
US20060257384A1 (en) 2006-11-16
BR122018068574B1 (pt) 2021-10-26
HK1162937A1 (en) 2012-09-07
WO2004087893A9 (en) 2006-03-30
CN102210717A (zh) 2011-10-12
JP2006521817A (ja) 2006-09-28
CA2521220C (en) 2014-05-27
BRPI0409206B1 (pt) 2018-11-06
ES2382930T3 (es) 2012-06-14
PT1613740E (pt) 2012-05-28
SE527555C2 (sv) 2006-04-11

Similar Documents

Publication Publication Date Title
SE0300994L (sv) Nya kompositioner och stammar
RS93604A (en) Substituted phenylacetamides and their use as glucokinase activators
HK1079104A1 (en) Orally administrable composition to human for the photoprotection of the skin
BRPI0514826A (pt) composições para o uso como inóculos de silagem, métodos de tratamento de materiais vegetais pré-ensilados e linhagem bacteriana substancialmente purificada
DK1143985T3 (da) Anvendelse af Lactobacillus salivarius
DE60233326D1 (de) Probiotische stämme der gattung lactobacillus salivarius
RU2008147883A (ru) Применение молочнокислых бактерий для уменьшения детской колики
WO2005007073A3 (en) Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
WO2002000042A3 (en) Compositions and methods for body weight management
WO2006065139A3 (en) Deacylation of lps in gram negative bacteria
AP2002002427A0 (en) Ppar compounds.
AU2003206926A1 (en) Cultivation method for micro-organisms and bioreactor
ATE335824T1 (de) Isolierte luziferasen sowie deren verwendung
MX2009006887A (es) Agentes para promover la produccion de iga.
NO20062639L (no) Bicykliske pyraxoloncytokininhibitorer
AU2003223968A1 (en) Composite elements
DE50206172D1 (de) Heil-und pflegemittel auf sauerteigbasis sowie verfahren zu seiner herstellung
ATE395414T1 (de) Glukose dehydrogenase und ihre herstellung
UA3507U (uk) Композиція квасу для окрошки
WO2004093825A3 (en) Methods for obtaining colonization factors from bacterial strains

Legal Events

Date Code Title Description
NUG Patent has lapsed